LabStyle Innovations Corp’s Dario device and complimentary mobile app are offering real time monitoring for diabetics while keeping caregivers in the loop at all times
Aside for being a serious and potentially life threatening condition, the onset of diabetes marks the beginning of a major intrusion into the diabetics life. A constant state of awareness must be kept about an entire bodily system, one’s glucose and blood sugar levels, something most people are completely oblivious about. A constant vigil must be kept to monitor these things. New devices must be attained and certain mathematical formulas and reasoning must become second nature.
To quote Dostoyevsky, “Man is a creature that can get used to anything, and I think that is the best definition of him.” But if Dostoyevsky clearly only knew reasonable men, for if he would have lived just a few more years he would have learned that there were actually twqo kinds of men , as George Bernard Shaw so eloquently points out; “The reasonable man adapts himself to the world; the unreasonable one persists in trying to adapt the world to himself. Therefore all progress depends on the unreasonable man.” Anyone who who’s ever had any dealings with us Israelis knows that when it comes to finding innovative solutions to affect an insufferable status quo – we can be pretty darn unreasonable.
Hardware and software to make the hard life of diabetics softer
Labstyle Innovations Corp. is another collections of ‘unreasonable’ Israelis who formed their startup to develop hardware and software solutions to address the daily challenges facing the life of a diabetic. The device they developed is called the Dario. This blood glucose monitoring device comes complete with lancet, strips and a meter that connects to the user’s smartphone and a website application enabling patients, medical professionals and caregivers to access their blood level data, and as a result, drives proactive state of intervention that is a for more aggressive and effective way of tackling the disease.
Hardware aside, dario’s Cloud-based mobile health platform (mHealth) was designed to capture the complete diabetic landscape, from monitoring to therapy. An iOS and Android app means that even those who use another, non-Dario monitoring device can still take advantage of Dario’s cloud services with its shared access to concerned parties, real-time, blood sugar level checks and useful insights and suggested courses of action based on reading outcomes.
The form factor
Although functionality is certainly the primary concern of any diabetic device, there is no getting around the fact that form factor never seemed to be a concern at all for device makers and most monitoring devices are rather standoutish. One look at the Dario and it is clear that Labstyle actually made an effort to put some actual style into their device and there is no doubt that they succeeded in this department. The Dario is sleek as it is functional and serves as an all-in-one, compact monitoring system. Long term goals see it as serving as an insulin delivery as well.
Market wise, diabetes is an unfortunate condition that affects four hundred million people worldwide according to the website of the International Diabetes Federation. As reported in a press release published by Transparency Market Research, the global diagnosis and monitoring devices market is expected to reach $26B by 2018. The total diabetes management market hit $50.8B in 2011 and is estimated to reach $98.4B come 2018.
Taking on Europe
Labstyle is only just beginning to scratch the surface of this market, having only recently announced the European launch date for their iOS application. The complementary app will be available for download from the Apple App Store on December 12, 2013 in the U.K., Australia and New Zealand.
“In a matter of weeks, we will begin the initial phase of building a user base of customers who will be able to first get to know and appreciate the feature rich deliverables of the Dario app and, soon after, integrate it with their Dario glucose monitoring device and website application,” said Erez Raphael, president and chief executive officer of LabStyle. “This is a very exciting time in the evolution of LabStyle. We are looking forward to achieving several important milestones in the coming months and to providing those in the diabetes community with a new way to approach and better manage their condition.”
Labstyle Innovations Corp. was founded in 2012. The company has offices in both Ramat Gan, Israel and in Newark, DE in the US. Labstyle has managed to raise a total of $12M in funding to date.